Coloplast A/S (0QBO) Price & Analysis

Coloplast A/S operates as a prominent global medical technology company, delivering specialized intimate healthcare products and services across Denmark, the United States, the United Kingdom, France, and numerous other international markets. Its business activities are organized into distinct divisions: Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care. Among its offerings, the firm provides an extensive selection of ostomy care items, including the SenSura Mio range, recognized for its adaptable fit to individual body shapes and superior discretion for diverse ostomy needs. This range is complemented by other SenSura Ostomy solutions and accessories available under the Brava brand. For continence management, Coloplast supplies products such as Conveen Active urine bags, SpeediCath catheters designed for both male and female patients, and the Peristeen transanal irrigation system. In the realm of wound and skin care, the company features advanced dressings like the Biatain Silicone conforming dressing and the Comfeel hydrocolloid dressing. Its comprehensive skin care line encompasses various cleansers, moisturizers, skin protectants, antifungal treatments, hand sanitizers, and odor control products, notably incorporating InterDry for skin fold management. Moreover, Coloplast engineers, manufactures, and markets devices tailored for the surgical treatment of various urological and gynecological disorders. These include solutions for conditions such as urinary stone disease, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Lastly, its voice and respiratory care segment offers specialized medical devices, with products for neck stomas sold under the Provox brand and tracheostomy products marketed under the TRACOE brand. Founded in 1954, Coloplast A/S maintains its principal corporate offices in Humlebæk, Denmark.